二十年来英国镰状细胞病女性的计划生育与咨询趋势

Trends in family planning and counselling for women with sickle cell disease in the UK over two decades.

作者信息

Eissa Asma A, Tuck Susan M, Rantell Khadija, Stott Daniel

机构信息

Clinical Research Fellow, Department of Obstetrics and Gynaecology, Royal Free Hospital, London, UK.

Consultant and Senior Lecturer, Department of Obstetrics and Gynaecology, Royal Free Hospital, London, UK.

出版信息

J Fam Plann Reprod Health Care. 2015 Apr;41(2):96-101. doi: 10.1136/jfprhc-2013-100763. Epub 2014 May 23.

Abstract

BACKGROUND

Pregnancies in women with sickle cell disease (SCD) are known to have high rates of maternal and fetal mortality and morbidity. Given these pregnancy-associated problems for women with SCD, advice both about pregnancy planning and about effective contraception are of paramount importance. This study sought to discover the contraception methods used by women with SCD, what complications women with SCD encounter with contraception, and their experiences of pre-pregnancy counselling and pregnancy planning, and how such issues may have changed over the past two decades.

METHOD

The study was a multicentre, interview-based, cross-sectional study. Interviews were carried out with 102 women with SCD, in north and central London during 2010, concerning their current and previous contraceptive use, their pregnancy history, their menstrual history, and the advice they received concerning pregnancy planning and contraception. Patient information was anonymised and ethical approval was obtained. These data were compared with data from a similar study undertaken in 1993.

RESULTS

There were significant differences in a number of key areas: the number of unplanned pregnancies decreased from 64% in 1993 to 53% in 2010. The number of women with SCD who were advised not to become pregnant also fell, from 36% to 15%. The use of combined oral contraceptive pills declined, from 45% of the women in 1993 to 31% in 2010. Conversely the use of depot medroxyprogesterone acetate contraception (DMPA) and the levonorgestrel intrauterine system (LNG-IUS) both increased.

CONCLUSIONS

Significant changes in the contraceptive methods used by women with SCD are demonstrated in the London population. LNG-IUS use in SCD has not been investigated before. There has been an encouraging decrease in the number of women with SCD who are advised not to become pregnant, perhaps reflecting an improvement in their overall health. Although the number of unplanned pregnancies has fallen, it remains high - emphasising the continuing need for women with SCD to have access to informed advice about pregnancy-associated issues and contraception.

摘要

背景

已知镰状细胞病(SCD)女性怀孕时母婴死亡率和发病率较高。鉴于SCD女性存在这些与妊娠相关的问题,关于妊娠计划和有效避孕的建议至关重要。本研究旨在了解SCD女性使用的避孕方法、SCD女性在避孕方面遇到的并发症、她们孕前咨询和妊娠计划的经历,以及这些问题在过去二十年中可能发生了哪些变化。

方法

该研究是一项基于访谈的多中心横断面研究。2010年,在伦敦北部和中部对102名SCD女性进行了访谈,内容涉及她们当前和以前的避孕使用情况、妊娠史、月经史以及她们收到的关于妊娠计划和避孕的建议。患者信息进行了匿名处理,并获得了伦理批准。将这些数据与1993年进行的一项类似研究的数据进行了比较。

结果

在一些关键领域存在显著差异:意外怀孕的比例从1993年的64%降至2010年的53%。被建议不要怀孕的SCD女性数量也有所下降,从36%降至15%。复方口服避孕药的使用有所减少,从1993年45%的女性使用降至2010年的31%。相反,醋酸甲羟孕酮长效避孕针(DMPA)和左炔诺孕酮宫内节育系统(LNG-IUS)的使用均有所增加。

结论

伦敦人群中SCD女性使用的避孕方法有显著变化。此前尚未对SCD患者使用LNG-IUS进行过研究。被建议不要怀孕的SCD女性数量出现了令人鼓舞的下降,这可能反映了她们整体健康状况的改善。尽管意外怀孕的数量有所下降,但仍然很高——这突出表明SCD女性持续需要获得有关妊娠相关问题和避孕的明智建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索